Difference between revisions of "Vinblastine (Velban)"
(updated content) |
|||
| Line 5: | Line 5: | ||
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information.<ref name="insert"></ref> | ||
| + | |||
| + | ==Diseases for which it is used== | ||
| + | *[[Aggressive Non-Hodgkin lymphoma]] | ||
| + | *[[Bladder cancer]] | ||
| + | *[[Hodgkin lymphoma, nodular lymphocyte-predominant]] | ||
| + | *[[Hodgkin lymphoma]] | ||
| + | *[[Melanoma]] | ||
| + | *[[Non-small cell lung cancer]] | ||
| + | *[[Testicular cancer]] | ||
==Patient drug information== | ==Patient drug information== | ||
Revision as of 20:49, 20 June 2013
General information
Class/mechanism: Vinca alkaloid, inhibits microtubule formation in the mitotic spindle, causing cell cycle arrest in metaphase.[1][2]
Route: IV
Extravasation: vesicant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Aggressive Non-Hodgkin lymphoma
- Bladder cancer
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Hodgkin lymphoma
- Melanoma
- Non-small cell lung cancer
- Testicular cancer
Patient drug information
- Vinblastine (Velban) patient drug information (Chemocare)[3]
- Vinblastine (Velban) patient drug information (UpToDate)[4]
Also known as
Alkaban-AQ, Blastovin, Cellblastin, Chlorhexamide, Cytoblastine, Erbablas, Exal, Exal 1, Faulblastina, Lemblastine, Periblastine, Rabinefil, Trav Vinblastine, Velban, Velbastine, Velbe, Vinblasin, Vinblastin, Vinblastin-Teva, Vinblastina, Vinblastina Filaxis, Vinblastine, Vinblastine Comp, Vinblastine Sulfate, Vinblastine Sulphate, Vinblastine Tillot, Vinblastine Wyeth Pharmaceutic, Vinblastin Kyorin, vincaleukoblastine, VLB.
References
- Drug index
- Chemotherapy
- Vesicant chemotherapy
- Microtubule inhibitors
- Vinca alkaloids
- Bladder cancer medications
- Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Melanoma medications
- Aggressive Non-Hodgkin lymphoma medications
- Non-small cell lung cancer medications
- Testicular cancer medications